In the latest trading session, Tilray Brands, Inc. (TLRY) closed at $10.93, a -10.04% decrease from the previous day, underperforming the S&P 500, Dow, and Nasdaq. However, the company’s shares have risen by 12.5% in the past month, outpacing the Medical sector and S&P 500.

Analysts anticipate Tilray Brands, Inc. to report earnings of -$0.14 per share, an 86% increase year-over-year, with projected revenue of $209.65 million, a 0.62% decline from the previous year. Zacks Consensus Estimates for the full year forecast earnings of -$0.44 per share and revenue of $866.74 million.

Investors should pay attention to analyst estimate changes for Tilray Brands, Inc. as they often reflect short-term business trends. The Zacks Rank system, currently holding Tilray Brands, Inc. at #3 (Hold), incorporates these changes and has historically outperformed with #1 stocks averaging a +25% annual gain since 1988.

The Medical – Products industry, which includes Tilray Brands, Inc., has a Zacks Industry Rank of 165, placing it in the bottom 34% of all industries. Utilize Zacks.com to track stock-moving metrics and industry rankings for informed trading decisions.

For investors seeking potential high-growth stocks, Zacks experts have identified 5 stocks set to double, including disruptive forces, compelling investments, and industry leaders. These picks offer the opportunity to capitalize on significant gains, with past recommendations soaring as high as +232%.

Read more at NASDAQ: Why Tilray Brands, Inc. (TLRY) Dipped More Than Broader Market Today